Pull to refresh
Logo
Marvell agrees to buy Lumentum in all-stock AI optics deal

Marvell agrees to buy Lumentum in all-stock AI optics deal

Money Moves

The $115 billion headline is shrinking: Marvell's stock slide has cut the value of its fixed share offer, and China's antitrust review is still the biggest hurdle.

Overview

Updated 3 days ago

Marvell Technology agreed on November 2 to buy Lumentum for about $115 billion in stock, offering 4.5 Marvell shares for each Lumentum share. The value of that fixed exchange ratio has since fallen with Marvell's stock: at the November 6 close it was worth about $635 per Lumentum share, down from $1,132 at signing.

Marvell shares have dropped about 44% since October 28, before deal talks surfaced. A broad chip selloff on November 5 deepened the slide; Lumentum closed near $510 that day, below the $913.95 it traded at before the talks. Bank of America cut Marvell to neutral on November 3, citing China's review and dilution, and the companies still target a close in the first half of 2028.

Why it matters

One company would sell both the processor and the laser at each optical link in an AI cluster, if regulators in Washington and Beijing agree.

Questions about this story

Free account needed to ask — your question is kept and asked for you right after sign-up. Answers are public.

No questions yet — be the first to ask.

Key Indicators

$115B
Implied enterprise value
Equity value was about $102.5 billion at signing; the rest is assumed net debt.
23.9%
Premium to unaffected price
Measured against Lumentum's October 28 close, before deal speculation surfaced.
4.5 : 1
Fixed exchange ratio
Marvell shares issued per Lumentum share; the value moves with Marvell's stock price.
67% / 33%
Ownership split after closing
Marvell holders keep 67% of the combined company on a fully diluted basis; Lumentum holders take 33%.
$635
Offer value at Nov. 6 close
4.5 Marvell shares at $141 each, down from $1,132 per Lumentum share at signing.
$1B+
Annual cost savings targeted
Management's estimated run-rate synergies once the companies are integrated.
-44%
Marvell shares since Oct. 28
Closed at $141 on November 6, down from $252 before deal talks surfaced.

Voices

Curated perspectives — historical figures and your fellow readers.

Sign up to generate historical perspectives on this story.

People Involved

Organizations Involved

Timeline

2026 November 2026

9 events Latest: 5 days ago
Tap a bar to jump to that date
  1. Marvell ends week 44% below pre-deal close

    Latest Market

    Shares closed at $141, putting the fixed exchange ratio at about $635 per Lumentum share, down from $1,132 at signing.

  2. Lumentum closes near $510 as deal value shrinks

    Market

    Marvell closed at $133.55 and Lumentum near $510 as a broad chip selloff hit semiconductor stocks. At that price, the fixed 4.5-share exchange ratio was worth about $601 per Lumentum share.

  3. Bank of America downgrades Marvell

    Analyst reaction

    Cut to neutral from buy, price target $225 from $400, citing China review and dilution.

  4. TrendForce flags China review focus

    Analyst reaction

    The research firm said Beijing's review will center on whether the merged company could restrict Chinese module makers' access to lasers or bundle them with Marvell's signal chips.

  5. Marvell agrees to buy Lumentum

    Deal

    All-stock deal at 4.5 Marvell shares per Lumentum share, $115 billion enterprise value.

  6. Marvell files Form 425 on merger terms

    Filing

    The filing lists closing conditions: both shareholder votes, US antitrust clearance and other regulatory approvals, including China's. A separate Form S-4 will serve as the merger prospectus.

  7. Unaffected closing prices set the baseline

    Market

    Last trading day before speculation; the 23.9% premium is measured from here.

  8. Merger talks reported

    Market

    After talks surface, Lumentum falls about 8% and Marvell about 22%.

  9. Nvidia takes stakes in both companies

    Investment

    Nvidia invests $2 billion each in Marvell and Lumentum.

Scenarios

1

Deal closes in 2028 as signed

Likely Resolves by Q2 2028

Discussed by: Marvell and Lumentum management, in the merger announcement

Both shareholder votes pass, US and European reviews clear, and Chinese regulators allow the deal through in time for the first half of 2028 outside date. Marvell absorbs Lumentum's laser fabs and transceiver line and sells a combined optical engine. The $1 billion in annual cost cuts arrive on the schedule management has described.

2

China review stretches past the outside date

Possible Resolves by End of 2028

Discussed by: Bank of America analyst Vivek Arya, in a November 2 note

Arya named the extended regulatory process, China included, as his first concern about the deal. A prolonged review would leave both companies in limbo for more than a year, with Lumentum unable to take on conflicting customers and Marvell carrying the overhang.

3

Shareholders or a rival bidder change the terms

Unlikely Resolves by End of 2027

Discussed by: Not yet a consensus view; the all-stock structure and falling Marvell price make it a live question

Because the exchange ratio is fixed, every drop in Marvell's share price cuts what Lumentum holders receive. A large enough decline could push Lumentum directors to reopen terms, or invite a competing offer. Marvell shareholders could also vote down the share issuance needed to fund the deal.

4

China clears the deal with conditions on laser supply

Possible Resolves by Q2 2028

Discussed by: TrendForce, in a November 3 research note

TrendForce expects China's regulator to treat access to Lumentum lasers as the central question, because Chinese module makers are leading suppliers of 800G and 1.6T transceivers and depend on Marvell signal chips and Lumentum laser sources. Approval with behavioral commitments would let the deal close while limiting how the combined company sells to rivals.

5

Beijing blocks the deal outright

Possible Resolves by Aug 31, 2028

Discussed by: TrendForce and The Inference, which examined China's review

China's antitrust regulator could refuse the transaction rather than impose conditions. TrendForce said the review will turn on whether Chinese module makers keep access to Lumentum's lasers. A block would leave Coherent as the large laser supplier outside a chip designer's control.

Historical Context

3 moments from history that rhyme with this story — and how they unfolded.

October 2020 – February 2022

AMD buys Xilinx (2020–2022)

AMD agreed to buy Xilinx in an all-stock deal worth roughly $49 billion, one of the largest chip mergers ever attempted. The transaction needed approval from regulators in the US, Europe and China, and China's sign-off arrived only near the end of the 18-month process.

Then

The deal closed in February 2022 after China's regulator granted conditional approval.

Now

It established that large all-stock semiconductor mergers can clear Beijing, but only slowly and with conditions attached.

Why this matters now

The Marvell-Lumentum deal follows the same shape: fixed exchange ratio, long regulatory calendar, and China as the decisive last approval.

May 2022 – November 2023

Broadcom buys VMware (2022–2023)

Broadcom agreed to buy software maker VMware for about $69 billion, then spent 18 months clearing reviews in the US, Europe, the UK and China. Regulators demanded behavioral commitments on pricing and interoperability before allowing it through.

Then

The deal closed in November 2023 after Broadcom made concessions to multiple agencies.

Now

It set the template for how long a deal of this size takes and how much remedy negotiating it requires.

Why this matters now

Marvell has targeted the first half of 2028 for closing, a timeline that assumes a review as long as Broadcom's.

September 2020 – February 2022

Nvidia's bid for Arm (2020–2022)

Nvidia agreed to buy chip designer Arm for about $40 billion. Regulators in the US, UK and Europe challenged the deal on competition grounds, and Arm's owner SoftBank eventually moved to sell shares to the public instead.

Then

The acquisition was abandoned in February 2022.

Now

It became the clearest example of a semiconductor merger failing outright on antitrust grounds.

Why this matters now

It is the downside case for Marvell: a large, strategically motivated chip acquisition that regulators can simply refuse.

Sources

(17)